• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于太赫兹光谱数据预测脑胶质瘤的 IDH 突变状态。

Prediction of IDH mutation status of glioma based on terahertz spectral data.

机构信息

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

School of Automation and Electrical Engineering, University of Science and Technology Beijing, Beijing, China.

出版信息

Spectrochim Acta A Mol Biomol Spectrosc. 2023 Jul 5;295:122629. doi: 10.1016/j.saa.2023.122629. Epub 2023 Mar 17.

DOI:10.1016/j.saa.2023.122629
PMID:36958244
Abstract

Gliomas are the most common type of primary tumor in the central nervous system in adults. Isocitrate dehydrogenase (IDH) mutation status is an important molecular biomarker for adult diffuse gliomas. In this study, we were aiming to predict IDH mutation status based on terahertz time-domain spectroscopy technology. Ninety-two frozen sections of glioma tissue from nine patients were included, and terahertz spectroscopy data were obtained. Through Least Absolute Shrinkage and Selection Operator (LASSO), Principal component analysis (PCA), and Random forest (RF) algorithms, a predictive model for predicting IDH mutation status in gliomas was established based on the terahertz spectroscopy dataset with an AUC of 0.844. These results indicate that gliomas with different IDH mutation status have different terahertz spectral features, and the use of terahertz spectroscopy can establish a predictive model of IDH mutation status, providing a new way for glioma research.

摘要

神经胶质瘤是成年人中枢神经系统最常见的原发性肿瘤。异柠檬酸脱氢酶(IDH)突变状态是成人弥漫性神经胶质瘤的重要分子生物标志物。在这项研究中,我们旨在基于太赫兹时域光谱技术预测 IDH 突变状态。纳入了 9 名患者的 92 个神经胶质瘤组织冷冻切片,并获得了太赫兹光谱数据。通过最小绝对值收缩和选择算子(LASSO)、主成分分析(PCA)和随机森林(RF)算法,基于太赫兹光谱数据集建立了预测 IDH 突变状态的预测模型,其 AUC 为 0.844。这些结果表明,具有不同 IDH 突变状态的神经胶质瘤具有不同的太赫兹光谱特征,并且太赫兹光谱技术的使用可以建立 IDH 突变状态的预测模型,为神经胶质瘤研究提供了一种新方法。

相似文献

1
Prediction of IDH mutation status of glioma based on terahertz spectral data.基于太赫兹光谱数据预测脑胶质瘤的 IDH 突变状态。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Jul 5;295:122629. doi: 10.1016/j.saa.2023.122629. Epub 2023 Mar 17.
2
Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive L-[methyl-11C] methionine cohort study with two PET scanners.弥散性 glioma 术前预测 IDH 突变状态和 WHO 分级的临床放射组学分析的开发和验证:两种 PET 扫描仪的连续 L-[甲基-11C]蛋氨酸队列研究。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1423-1435. doi: 10.1007/s00259-023-06562-0. Epub 2023 Dec 19.
3
Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.机器学习揭示了可预测弥漫性低级别和高级别神经胶质瘤异柠檬酸脱氢酶和 1p/19q 状态的多模态 MRI 模式。
J Neurooncol. 2019 Apr;142(2):299-307. doi: 10.1007/s11060-019-03096-0. Epub 2019 Jan 19.
4
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.弥散加权和灌注加权 MRI 放射组学模型可预测弥漫性低级别胶质瘤中的异柠檬酸脱氢酶 (IDH) 突变和肿瘤侵袭性。
Eur Radiol. 2020 Apr;30(4):2142-2151. doi: 10.1007/s00330-019-06548-3. Epub 2019 Dec 11.
5
RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.基于 RNA 编辑的弥漫性神经胶质瘤分类:预测异柠檬酸脱氢酶突变和染色体 1p/19q 联合缺失。
BMC Bioinformatics. 2019 Dec 24;20(Suppl 19):659. doi: 10.1186/s12859-019-3236-0.
6
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.多模态磁共振成像特征可预测高级别胶质瘤中的异柠檬酸脱氢酶基因型。
Neuro Oncol. 2017 Jan;19(1):109-117. doi: 10.1093/neuonc/now121. Epub 2016 Jun 26.
7
Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.在临床环境中通过磁共振波谱技术无创评估脑胶质瘤异柠檬酸脱氢酶基因突变状态。
J Neurosurg. 2018 Feb;128(2):391-398. doi: 10.3171/2016.10.JNS161793. Epub 2017 Mar 3.
8
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.T2-FLAIR 错配征象作为弥漫性低级别胶质瘤 IDH 和 1p/19q 状态的影像学生物标志物:一项基于贝叶斯方法评估诊断试验性能的系统评价。
Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660.
9
7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma grading.7 特斯拉磁共振波谱成像预测 IDH 状态和胶质瘤分级。
Cancer Imaging. 2024 May 27;24(1):67. doi: 10.1186/s40644-024-00704-9.
10
An Intra- and Inter-Modality Fusion Model Using MR Images for Prediction of Glioma Isocitrate Dehydrogenase (IDH) Mutation.基于 MR 图像的胶质瘤异柠檬酸脱氢酶(IDH)突变预测的一种模态内和模态间融合模型。
Annu Int Conf IEEE Eng Med Biol Soc. 2022 Jul;2022:198-202. doi: 10.1109/EMBC48229.2022.9871800.

引用本文的文献

1
Rapid diagnosis of TERT promoter mutation using Terahertz absorption spectroscopy in glioblastoma.利用太赫兹吸收光谱法在胶质母细胞瘤中快速诊断TERT启动子突变
Sci Rep. 2025 May 27;15(1):18480. doi: 10.1038/s41598-025-03161-x.
2
Effect of terahertz radiation on cells and cellular structures.太赫兹辐射对细胞及细胞结构的影响。
Front Optoelectron. 2025 Jan 27;18(1):2. doi: 10.1007/s12200-024-00146-y.
3
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment.
神经肿瘤学中的人工智能:脑肿瘤诊断、预后及精准治疗的进展与挑战
NPJ Precis Oncol. 2024 Mar 29;8(1):80. doi: 10.1038/s41698-024-00575-0.